GL1X · GenesisL1 explorer

UniProt P19793

Retinoic acid receptor RXR-alpha (P19793)

Retinoic acid receptor RXR-alpha (UniProt P19793): 177 experimental structures on GenesisL1, 28 ligands bound, 16 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P19793
Protein
Retinoic acid receptor RXR-alpha
Experimental structures
177
Predicted models
0
Ligands
28
Pockets
16 · 2 records with a druggable one

Structures

177 records of P19793 in the MolNFT archive: 177 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
1BY4Structure and mechanism of the homodimeric assembly of the rxr on DNAx-ray diffractionA, B, C, D——
1BY4Structure and mechanism of the homodimeric assembly of the rxr on DNAx-ray diffractionA, B, C, D——
1DSZStructure of the RXR/RAR DNA-binding domain heterodimer in complex with the retinoic acid response…x-ray diffractionB——
1DSZStructure of the RXR/RAR DNA-binding domain heterodimer in complex with the retinoic acid response…x-ray diffractionB——
1FBYCrystal structure of the human rxr alpha ligand binding domain bound to 9-cis retinoic acidx-ray diffractionA, B——
1FBYCrystal structure of the human rxr alpha ligand binding domain bound to 9-cis retinoic acidx-ray diffractionA, B——
1FM6The 2.1 ångström resolution crystal structure of the heterodimer of the human rxralpha and…x-ray diffractionA, U——
1FM6The 2.1 ångström resolution crystal structure of the heterodimer of the human rxralpha and…x-ray diffractionA, U——
1FM9The 2.1 ångström resolution crystal structure of the heterodimer of the human rxralpha and…x-ray diffractionA——
1FM9The 2.1 ångström resolution crystal structure of the heterodimer of the human rxralpha and…x-ray diffractionA——
1G1UThe 2.5 ångström resolution crystal structure of the rxralpha ligand binding domain in tetramer in…x-ray diffractionA, B, C, D——
1G1UThe 2.5 ångström resolution crystal structure of the rxralpha ligand binding domain in tetramer in…x-ray diffractionA, B, C, D——
1G5YThe 2.0 ångström resolution crystal structure of the rxralpha ligand binding domain tetramer in the…x-ray diffractionA, B, C, D——
1G5YThe 2.0 ångström resolution crystal structure of the rxralpha ligand binding domain tetramer in the…x-ray diffractionA, B, C, D——
1K74The 2.3 Angstrom resolution crystal structure of the heterodimer of the human PPARgamma and…x-ray diffractionA——
1K74The 2.3 ångström resolution crystal structure of the heterodimer of the human ppargamma and…x-ray diffractionA——
1MV9Crystal Structure of the human RXR alpha ligand binding domain bound to the eicosanoid DHA (Docosa…x-ray diffractionA——
1MV9Crystal structure of the human rxr alpha ligand binding domain bound to the eicosanoid dha (docosa…x-ray diffractionA——
1MVCCrystal structure of the human RXR alpha ligand binding domain bound to the synthetic agonist…x-ray diffractionA——
1MVCCrystal structure of the human rxr alpha ligand binding domain bound to the synthetic agonist…x-ray diffractionA——
1MZNCRYSTAL STRUCTURE at 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING…x-ray diffractionA, C, E, G——
1MZNCrystal structure at 1.9 angstroems resolution of the homodimer of human rxr alpha ligand binding…x-ray diffractionA, C, E, G——
1R0NCrystal Structure of Heterodimeric Ecdsyone receptor DNA binding complexx-ray diffractionA——
1R0NCrystal structure of heterodimeric ecdsyone receptor DNA binding complexx-ray diffractionA——
1RDTCrystal Structure of a new rexinoid bound to the RXRalpha ligand binding doamin in the…x-ray diffractionA——
1RDTCrystal structure of a new rexinoid bound to the rxralpha ligand binding doamin in the…x-ray diffractionA——
1RXRHigh resolution solution structure of the retinoid X receptor DNA binding domain, NMR, 20 structuresolution nmrA——
1RXRHigh resolution solution structure of the retinoid X receptor DNA binding domain, NMR, 20 structuresolution nmrA——
1XLSCrystal structure of the mouse CAR/RXR LBD heterodimer bound to TCPOBOP and 9cRA and a TIF2 peptide…x-ray diffractionA, B, C, D——
1XLSCrystal structure of the mouse CAR/RXR lbd heterodimer bound to tcpobop and 9CRA and a TIF2 peptide…x-ray diffractionA, B, C, D——
1XV9crystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid, and…x-ray diffractionA, C——
1XV9Crystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid, and…x-ray diffractionA, C——
1XVPcrystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid and CITCOx-ray diffractionA, C——
1XVPCrystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid and citcox-ray diffractionA, C——
1YNWCrystal Structure of Vitamin D Receptor and 9-cis Retinoic Acid Receptor DNA-Binding Domains Bound…x-ray diffractionB——
1YNWCrystal structure of vitamin D receptor and 9-cis retinoic acid receptor DNA-binding domains bound…x-ray diffractionB——
2ACLLiver X-Receptor alpha Ligand Binding Domain with SB313987x-ray diffractionA, C, E, G——
2ACLLiver X-receptor alpha ligand binding domain with SB313987x-ray diffractionA, C, E, G——
2NLLRetinoid X receptor-thyroid hormone receptor DNA-binding domain heterodimer bound to thyroid…x-ray diffractionA——
2NLLRetinoid X receptor-thyroid hormone receptor DNA-binding domain heterodimer bound to thyroid…x-ray diffractionA——
2P1TCrystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with…x-ray diffractionA——
2P1TCrystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with…x-ray diffractionA——
2P1UCrystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with…x-ray diffractionA——
2P1UCrystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with…x-ray diffractionA——
2P1VCrystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with…x-ray diffractionA——
2P1VCrystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with…x-ray diffractionA——
2ZXZCrystal structure of the human RXR alpha ligand binding domain bound to a synthetic agonist…x-ray diffractionA——
2ZXZCrystal structure of the human rxr alpha ligand binding domain bound to a synthetic agonist…x-ray diffractionA——
2ZY0Crystal structure of the human RXR alpha ligand binding domain bound to a synthetic agonist…x-ray diffractionA, C——
2ZY0Crystal structure of the human rxr alpha ligand binding domain bound to a synthetic agonist…x-ray diffractionA, C——
3DZUIntact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with BVT.13, 9-cis Retinoic…x-ray diffractionA——
3DZUIntact ppar gamma - rxr alpha nuclear receptor complex on DNA bound with BVT.13, 9-cis retinoic…x-ray diffractionA——
3DZYIntact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with Rosiglitazone, 9-cis…x-ray diffractionA——
3DZYIntact ppar gamma - rxr alpha nuclear receptor complex on DNA bound with rosiglitazone, 9-cis…x-ray diffractionA——
3E00Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with GW9662, 9-cis Retinoic…x-ray diffractionA——
3E00Intact ppar gamma - rxr alpha nuclear receptor complex on DNA bound with GW9662, 9-cis retinoic…x-ray diffractionA——
3E94Crystal structure of RXRalpha ligand binding domain in complex with tributyltin and a coactivator…x-ray diffractionA——
3E94Crystal structure of rxralpha ligand binding domain in complex with tributyltin and a coactivator…x-ray diffractionA——
3FALhumanRXR alpha & mouse LXR alpha complexed with Retenoic acid and GSK2186x-ray diffractionA, C——
3FALHumanrxr alpha & mouse lxr alpha complexed with retenoic acid and GSK2186x-ray diffractionA, C——

117 records more on the page itself.

Ligands

  • 9CR · (9cis)-retinoic acid · in 8 records
  • ZN · Zinc ion · in 6 records
  • CL · Chloride ion · in 5 records
  • 9HF · 1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl) benzotriazole-5-carboxylic acid · in 4 records
  • PO4 · Phosphate ion · in 3 records
  • 4CU · (~{E})-3-[4-oxidanyl-3-(5-prop-2-enyl-2-propoxy-phenyl)phenyl]prop-2-enoic acid · in 2 records
  • 7A4 · [(1Z)-5-fluoro-2-methyl-1-{[4-(propan-2-yl) phenyl]methylidene}-1H-inden-3-yl]acetic acid · in 2 records
  • BR · Bromide ion · in 2 records
  • CA · Calcium ion · in 2 records
  • E8L · 6-[ethyl-[3-(2-methoxyethoxy)-4-propan-2-yl-phenyl]amino]pyridine-3-carboxylic acid · in 2 records
  • E8O · 6-[ethyl-[4-(2-methylpropoxy)-3-propan-2-yl-phenyl]amino]pyridine-3-carboxylic acid · in 2 records
  • I5W · (~{E})-3-[3-(2-methyl-5-phenyl-phenyl)-4-oxidanyl-phenyl]prop-2-enoic acid · in 2 records
  • J57 · (~{E})-3-[4-oxidanyl-3-(3-propan-2-ylphenyl) phenyl]prop-2-enoic acid · in 2 records
  • SJZ · (~{E})-3-[3-(2-methyl-3-phenyl-phenyl)-4-oxidanyl-phenyl]prop-2-enoic acid · in 2 records
  • SO4 · Sulfate ion · in 2 records
  • WY5 · 7-oxidanyl-2-oxidanylidene-6-(3,5,5,8,8-pentamethyl-6, 7-dihydronaphthalen-2-yl)chromene-3-carboxylic acid · in 2 records
  • 754 · (2E,4E,6Z)-3-methyl-7-(5,5,8,8-tetramethyl-3-propoxy-5, 6,7,8-tetrahydronaphthalen-2-yl)octa-2,4,6-trienoic acid · in 1 record
  • 7BE · (2~{R})-6,6,9,9-tetramethylspiro[3,4,7,8-tetrahydrobenzo[g]chromene-2,2'-3,4-dihydrochromene]-6'-carboxylic acid · in 1 record
  • 7O0 · (~{E})-3-[4-oxidanyl-3-[3-(phenylmethyl) phenyl]phenyl]prop-2-enoic acid · in 1 record
  • CPS · 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate · in 1 record
  • E80 · 6-[ethyl-[3-(2-methylpropoxy)-4-propan-2-yl-phenyl]amino]pyridine-3-carboxylic acid · in 1 record
  • LFZ · 2-[4-[3,5-bis(trifluoromethyl)phenyl]phenyl]ethanoic acid · in 1 record
  • LG2 · 6-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl]pyridine-3-carboxylic acid · in 1 record
  • PLM · Palmitic acid · in 1 record
  • T2K · 3-[5-[3,5-bis(chloranyl)phenyl]-4-phenyl-1,3-oxazol-2-yl]propanoic acid · in 1 record
  • T72 · 3-(5-(3,5-bis(trifluoromethyl)phenyl)-4-phenyloxazol-2-yl)propanoic acid · in 1 record
  • UGW · 2,4-di~{tert}-butylphenol · in 1 record
  • WZ6 · 1-[3-(2-ethoxyethoxy)-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl]-2-(trifluoromethyl) benzimidazole-5-carboxylic acid · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.